OxTalks will soon move to the new Halo platform and will become 'Oxford Events.' There will be a need for an OxTalks freeze. This was previously planned for Friday 14th November – a new date will be shared as soon as it is available (full details will be available on the Staff Gateway).
In the meantime, the OxTalks site will remain active and events will continue to be published.
If staff have any questions about the Oxford Events launch, please contact halo@digital.ox.ac.uk
It is almost 15 years since the first proof-of-principle report of DBS for treatment resistant depression. Progress continues, with implementation of refined techniques for surgical targeting and emerging clues as to which patients are most likely to benefit. Additional perspectives on trajectory, time-course, and sustainability of DBS effects have been advanced by device innovations that address mechanisms at the neural level. Current studies are further poised to explore strategies to maximize rehabilitative gains of patients once the DBS itself is optimized. Together, these studies provide a unique opportunity to form a more comprehensive and nuanced understanding of illness and recovery.
